Sumar Sponsorii manifestării - Medicina Modernă

BIBLIOGRAFIE
1. Sternbach H, The Serotonine Syndrome, Am J Psychiatry,
1991, 148(6): 705-713.
2. Ozdemir S, Yalung I, Aker AT, Serotonin Syndrome
Associated With Sertraline Monotherapy
3. at Therapeutic Doses, Progress in Neuro-
Psychopharmacology & Biological Psychiatry, 2008, 32: 897–
898.
4. Cojocaru V, Cojocaru LE, Mungiu OC, Analiza efectelor
adverse şi interacţiunilor trazodonei prescrise la Cabinetul de
Psihiatrie al Ambulatorului „Sf Spiridon” Iaşi în perioada 31
ianuarie 2006-31 ianuarie 2007, Sibiul Medical, 2008, 2, Vol
19: 158-162.
5. Mills KC, Serotonin Syndrome: A Clinical Update, 1997,
Critical Care Clinics, !3(4): 763-783.
6. Jackson N, Doherty J, Coulter S, Neuropsychiatric
Complications of Commonly Used Palliative Care Drugs,
Postgrad Med J, 2008; 84: 121-126.
7. Prator BC, Serotonin Syndrome, J Neurosci Nurs, 2006;
38(2): 102-105.
8. Stahl MS, Stahl`s Essential Pharmacology. Neuroscientific
Basis and Practical Applications, Third Edition, Cambridge
University Press, New York, 2008, 595-597.
9. Katzung GB, Basic and Clinical Pharmacology, 10th
Edition, Lange Medical Books, McGraw-Hill Companies Inc.,
New York, 2007.
10. Scott Obach R, Cox L, Tremaine LM, Sertraline is
Metabolized by Multiple Cytochrome P 450 Enzymes,
Monoamine Oxydazes, and Glucuronyl Transferazes in Human:
An In Vitro Study, Drug Metabolism and Disposition, 2005;
33: 262-270.
11. http://www.rxlist.com/ginkgo-biloba-drug.htm la 2 mai
2009.
76
12. Sadler C, Charrois TL, Vohra S, Ginkgo Biloba: Practical
Management of Adverse Effects and Drug Interactions,
CPJ/RPC, 5, 139: 32-35.
13. Uchida S, Yamada H, Maruyama S, Ohmory Y, Watanabe
H, et al, Effects of Gikgo Biloba Extract on Pharmacokynetics
and Pharmacodynamics of Tolbutamide and Midazolam in
Healthy Volunteers, J Clin Pharmacol, 2006, 46(11): 1290-
1298.
14. Rosenblatt M, Spontaneous Hyphema Associated with
Ingestion of Ginkgo biloba Extract, NEMJ, 1997, 15, 336:
1108.
15. Gaudineau C, Beckerman R, Welbourn S, Auclair K,
Inhibition of Human P 450 Enzymes by Multiple Constituents
of the Ginkgo Biloba Extract, Biochemical and Biophysical
Research Communications, 318, 4: 1072-1078.
16. Granger AS, Ginkgo Biloba is Precipitating Epileptic
Seizures, Age Ageing, 2001, 30(6):523-5.
17. Tracy ST, Kingston RL, Herbal Products: Toxicology and
Clinical Pharmacology 2nd Edition, Springer-Verlag New
York: LLC; 2006.
18. Yin OQ, Tomlinson B, Waye MM, Chow AH, Chow MS,
Pharmacogenetics and Herb-Drug Interactions: Experience
With Ginkgo Biloba and Omeprazole, Live Sci, 2004,
14(12):841-50.
19. White H, Scates PW, Cooper BR. Extracts of Ginkgo
Biloba Leaves Inhibit Monoamine Oxidase, Life Sci,
58(16):1315-21.
20. Li L, Stanton JD, Tolson AH, Luo Y, Wang H, Bioactive
Terpenoids and Flavonoids From Ginkgo Biloba Extract Induce
the Expression of Hepatic Drug-Metabolizing Enzymes
Through Pregnane X Receptor, Constitutive Androstane
Receptor, and Aryl Hdrocarbon Rceptor-Mediated Pathways,
Pharm Res, 2009, 26(4):872-82.